Clinical Trial Update: The Mechanism of Action of Unite Biomatrix in Venous Leg Ulcers [NA]

View source ↗

Summary

A clinical trial evaluating the mechanism of action of Unite Biomatrix for venous leg ulcers has been withdrawn from clinicaltrials.gov.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Leg Ulcers

Drugs mentioned

• Unite Biomatrix

Snippet

Sponsor: Baxter Healthcare Corporation | Conditions: Venous Leg Ulcers | NA | Status: WITHDRAWN